478 related articles for article (PubMed ID: 24755121)
1. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.
Liang CA; Jambusaria-Pahlajani A; Karia PS; Elenitsas R; Zhang PD; Schmults CD
J Am Acad Dermatol; 2014 Oct; 71(4):781-6. PubMed ID: 24755121
[TBL] [Abstract][Full Text] [Related]
2. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases].
Zhang J; Wu N; Xia C; Wei X; Shi QL; Zhou XJ; Ma J
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):753-7. PubMed ID: 24447553
[TBL] [Abstract][Full Text] [Related]
3. Dermatofibrosarcoma protuberans: A retrospective study of clinicopathologic features and related Akt/mTOR, STAT3, ERK, cyclin D1, and PD-L1 expression.
Park S; Cho S; Kim M; Park JU; Jeong EC; Choi E; Park JH; Lee C; Chang MS
J Am Acad Dermatol; 2018 Nov; 79(5):843-852. PubMed ID: 29792909
[TBL] [Abstract][Full Text] [Related]
4. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.
Abbott JJ; Oliveira AM; Nascimento AG
Am J Surg Pathol; 2006 Apr; 30(4):436-43. PubMed ID: 16625088
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for distant metastasis of dermatofibrosarcoma protuberans.
Hayakawa K; Matsumoto S; Ae K; Tanizawa T; Gokita T; Funauchi Y; Motoi N
J Orthop Traumatol; 2016 Sep; 17(3):261-6. PubMed ID: 27289468
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of fibrosarcomatous transformation in dermatofibrosarcoma protuberans: a cohort study.
Hoesly PM; Lowe GC; Lohse CM; Brewer JD; Lehman JS
J Am Acad Dermatol; 2015 Mar; 72(3):419-25. PubMed ID: 25582537
[TBL] [Abstract][Full Text] [Related]
8. Dermatofibrosarcoma Protuberans: A Clinicopathologic and Therapeutic Analysis of 254 Cases at a Single Institution.
Jing C; Zhang H; Zhang X; Yu S
Dermatol Surg; 2021 Feb; 47(2):e26-e30. PubMed ID: 32769521
[TBL] [Abstract][Full Text] [Related]
9. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases.
Díaz-Cascajo C; Weyers W; Borrego L; Iñarrea JB; Borghi S
Am J Dermatopathol; 1997 Dec; 19(6):562-7. PubMed ID: 9415611
[TBL] [Abstract][Full Text] [Related]
10. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
[TBL] [Abstract][Full Text] [Related]
11. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
[TBL] [Abstract][Full Text] [Related]
12. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.
Goldblum JR
Arch Pathol Lab Med; 1995 Mar; 119(3):238-41. PubMed ID: 7534057
[TBL] [Abstract][Full Text] [Related]
13. Metastatic potential of dermatofibrosarcoma protuberans with fibrosarcomatous change.
Minter RM; Reith JD; Hochwald SN
J Surg Oncol; 2003 Mar; 82(3):201-8. PubMed ID: 12619065
[TBL] [Abstract][Full Text] [Related]
14. Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables.
Erdem O; Wyatt AJ; Lin E; Wang X; Prieto VG
Am J Dermatopathol; 2012 Feb; 34(1):24-34. PubMed ID: 21785324
[TBL] [Abstract][Full Text] [Related]
15. A clinicopathologic review of a case series of dermatofibrosarcoma protuberans with fibrosarcomatous differentiation.
Kuzel P; Mahmood MN; Metelitsa AI; Salopek TG
J Cutan Med Surg; 2015; 19(1):28-34. PubMed ID: 25775660
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of fibrosarcomatous dermatofibrosarcoma protuberans and the construction of a back-propagation neural network recognition model.
Li Y; Liang J; Xu X; Jiang X; Wang C; Chen S; Xiang B; Ji Y
Orphanet J Rare Dis; 2021 Jan; 16(1):48. PubMed ID: 33499900
[TBL] [Abstract][Full Text] [Related]
17. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.
Bowne WB; Antonescu CR; Leung DH; Katz SC; Hawkins WG; Woodruff JM; Brennan MF; Lewis JJ
Cancer; 2000 Jun; 88(12):2711-20. PubMed ID: 10870053
[TBL] [Abstract][Full Text] [Related]
18. Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss.
Stacchiotti S; Astolfi A; Gronchi A; Fontana A; Pantaleo MA; Negri T; Brenca M; Tazzari M; Urbini M; Indio V; Colombo C; Radaelli S; Brich S; Dei Tos AP; Casali PG; Castelli C; Dagrada GP; Pilotti S; Maestro R
Mol Cancer Res; 2016 Sep; 14(9):820-9. PubMed ID: 27256159
[TBL] [Abstract][Full Text] [Related]
19. Fibrosarcomatous change in dermatofibrosarcoma protuberans.
Wrotnowski U; Cooper PH; Shmookler BM
Am J Surg Pathol; 1988 Apr; 12(4):287-93. PubMed ID: 3354755
[TBL] [Abstract][Full Text] [Related]
20. A progression to dermatofibrosarcoma protuberans with a fibrosarcomatous component: a special reference to the chromosomal aberrations.
Hamada M; Hirakawa N; Fukuda T; Furue M; Hori Y; Tsuneyoshi M
Pathol Res Pract; 1999; 195(7):451-60. PubMed ID: 10448661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
